Processa Pharmaceuticals, Inc. (PCSA)

Processa Pharmaceuticals Statistics

Total Valuation

PCSA has a market cap or net worth of $7.87 million. The enterprise value is $6.34 million.

Market Cap	7.87M
Enterprise Value	6.34M

Important Dates

The last earnings date was Thursday, May 7, 2026, after market close.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

PCSA has 2.66 million shares outstanding. The number of shares has increased by 878.52% in one year.

Current Share Class	2.66M
Shares Outstanding	2.66M
Shares Change (YoY)	+878.52%
Shares Change (QoQ)	+16.25%
Owned by Insiders (%)	2.22%
Owned by Institutions (%)	21.32%
Float	2.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.69
P/TBV Ratio	3.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.98

Current Ratio	0.98
Quick Ratio	0.85
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -464.99% and return on invested capital (ROIC) is -295.74%.

Return on Equity (ROE)	-464.99%
Return on Assets (ROA)	-193.89%
Return on Invested Capital (ROIC)	-295.74%
Return on Capital Employed (ROCE)	-569.59%
Weighted Average Cost of Capital (WACC)	9.81%
Revenue Per Employee	n/a
Profits Per Employee	-$1.18M
Employee Count	12
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -49.40% in the last 52 weeks. The beta is 1.01, so PCSA's price volatility has been similar to the market average.

Beta (5Y)	1.01
52-Week Price Change	-49.40%
50-Day Moving Average	2.77
200-Day Moving Average	4.63
Relative Strength Index (RSI)	55.10
Average Volume (20 Days)	61,796

Short Selling Information

The latest short interest is 135,440, so 5.09% of the outstanding shares have been sold short.

Short Interest	135,440
Short Previous Month	103,916
Short % of Shares Out	5.09%
Short % of Float	5.65%
Short Ratio (days to cover)	1.79

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-14.47M
Pretax Income	-14.11M
Net Income	-14.11M
EBITDA	-14.47M
EBIT	-14.47M
Earnings Per Share (EPS)	-$7.54

Balance Sheet

The company has $1.69 million in cash and n/a in debt, with a net cash position of $1.69 million or $0.64 per share.

Cash & Cash Equivalents	1.69M
Total Debt	n/a
Net Cash	1.69M
Net Cash Per Share	$0.64
Equity (Book Value)	2.54M
Book Value Per Share	0.95
Working Capital	-41,687

Cash Flow

Operating Cash Flow	-12.25M
Capital Expenditures	n/a
Depreciation & Amortization	1,204
Net Borrowing	-5,066
Free Cash Flow	-12.25M
FCF Per Share	-$4.60

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PCSA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-878.52%
Shareholder Yield	-878.52%
Earnings Yield	-175.60%
FCF Yield	-152.44%

Analyst Forecast

The average price target for PCSA is $25.00, which is 744.60% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.00
Price Target Difference	744.60%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 17, 2025. It was a reverse split with a ratio of 1:25.

Last Split Date	Dec 17, 2025
Split Type	Reverse
Split Ratio	1:25

Scores

Altman Z-Score	n/a
Piotroski F-Score	1